SSamsung Biologics Read More Samsung Biologics to acquire PolyPeptide in $1.8 billion deal | World NewsAugust 2, 2026 Samsung Biologics Co. agreed to acquire Switzerland’s PolyPeptide Group AG in an all-cash deal that values the…
SSamsung Biologics Read More Samsung Biologics to acquire PolyPeptide in $1.8 billion deal | World NewsJuly 21, 2026 Shares of Samsung Biologics declined as much as 3.3% in Seoul on Monday. PolyPeptide shares jumped as much…